The Propaganda for Reform in Proprietary Medicines, Vol. 1 of 2Council on Pharmacy and Chemistry (American Medical Association)
Science
The Propaganda for Reform in Proprietary Medicines, Vol. 1 of 2
Council on Pharmacy and Chemistry (American Medical Association)
Patent medicines
In June, 1912, further consideration of Dioradin was requested. The
American agent having promised a reform in the methods of advertising,
the Council considered the available evidence regarding the identity
and value of the preparation. Examination of evidence regarding the
composition of Dioradin--claimed to consist of radium chlorid, iodoform
and menthol in an ether-oil solution--showed serious discrepancies
as to the amount of radium as well as to the identity and amounts of
other constituents. It was further found that the experimental evidence
was insufficient and biased. Then, too, in view of the difficulty
of judging the effects of medicines in tuberculosis, the clinical
data were unconvincing. There was nothing to prove that the reported
improvements, even if they actually occurred, were to be ascribed to
the mixture as a whole rather than to any one of its constituents.
As a result of these findings, the Council voted that Dioradin be
refused recognition and that the publication of these facts be
authorized. In accordance with its regular procedure, it also submitted
the report to the agent. In reply the agent submitted evidence which
showed that he was not responsible for the misstatements about Dioradin
but offered no facts that affected the Council’s findings.
The entire matter having been referred to a second referee, minor
modifications of the first draft of the report were authorized. Since
then the Dioradin Company has submitted two reports of examinations
of Dioradin made for the company in Germany showing a higher radium
content than that previously found. These reports do not alter the
facts brought out in the report of the Council that the composition of
Dioradin has been variable, which past variability arouses a feeling of
uncertainty or lack of confidence. In view of this the amended report
was ordered published and appears below.
W. A. Puckner, Secretary.
_FIRST SUBMISSION OF DIORADIN_
Dioradin, a preparation for the treatment of consumption originated
by Dr. R. de Szendeffy, Budapest, Hungary, was submitted to the
Council by Louis Gero, Ltd., New York, with the following statement
of composition:
“A radio-active preparation of Menthol, Iodin and Radium Barium
Chlorid 1/10 of a drop; in ether solution.”
A circular which accompanied the submission stated:
“Preparation No. 3 of Dioradin contains not only terpins but also
iodin salts.... In view of the fact that emanations of the radium
as well as the combinations of the evasive iodin terpins enter into
the organism through the lung....”
Later these indefinite statements of composition were supplemented by
the following:
“In 100 c.c. there are:
1 gr. Iodoform.
5 " Menthol.
10 drops Radium chlorid solution
(1 milligr. in 100 c.c. of water).
5 gr. ether.
90 " Oil (ol. amygd. frig. press).”
Public-domain text, read in full here on John Shaqi.
Reviews
Reviews
No reviews yet
Be the first to share your thoughts on this work.
Elsewhere in the archive
Join the Discussion
Join the discussion
Sign in to leave a comment or review.
Sign InorCreate an account